TABLE 4.
Association of FABQW Scores and 6-Month Minimally Clinical Important Difference ODQ Scores for Patients Participating in These Clinical Trials
Cut-off Threshold | Cumulative Percentage | +LR (95% CI) | −LR (95% CI) |
---|---|---|---|
FABQW >5 | 20.6% | 1.19 (1.04-1.34) | 0.31 (0.16-0.46) |
FABQW >10 | 30.6% | 1.16 (1.01-1.31) | 0.64 (0.49-0.79) |
FABQW >15 | 45.0% | 1.42 (1.27-1.57) | 0.46 (0.31-0.61) |
FABQW >20 | 65.6% | 2.35 (2.20 -2.50) | 0.30 (0.15-0.45) |
FABQW >25 | 83.1% | 2.67 (2.52-2.82) | 0.65 (0.50-0.80) |
FABQW >30 | 90.6% | 2.50 (2.35-2.65) | 0.82 (0.67-0.97) |
FABQW >35 | 95.6% | 5.15 (5.00-5.30) | 0.83 (0.68-0.98) |
FABQW >40 | 99.4% | Insufficient data | Insufficient data |
Abbreviations: CI, confidence interval; FABQW, Fear-Avoidance Beliefs Questionnaire work scale; +LR, positive likelihood ratio; −LR, negative likelihood ratio; ODQ, Oswestry Disability Questionnaire.